AHS 2022: Top Interviews and Key Takeaways

As it does annually, the American Headache Society (AHS) held its scientific meeting in June 2022, bringing together thousands of experts and clinicians who care for patients with migraine and headache, as well as basic science researchers who seek to identify new mechanistic targets and implicated systems.

The sessions and presentations at AHS 2022 included topics such as the therapeutic potential of psychedelics, the need for standardized approaches to status migrainosus, the complexities of neuronal activity during migraine, the role of mindfulness practices for these patients, and the endocannabinoid system's implications in migraine, among others

Swipe through the slideshow below to browse our interviews with experts on-site, and be sure to check back for ongoing coverage from the conference! 

Click here for more coverage of headache and migraine from NeurologyLive^®, or for more coverage of AHS 2022, click here. 

REFERENCES
1. Estave P, Margol CL, Beeghly S, et al. Mechanisms of Mindfulness in Patients with Migraine: Results of a Qualitative Study. Presented at: AHS Annual Meeting; June 9-12, 2022; Denver, CO.
2. Largent-Milnes TM. How Does the Endocannabinoid System Affect Headache and Disorders? Presented at: AHS Annual Scientific Meeting; June 9-11, 2022; Denver, CO.
3. VanderPluym J, Mangipudi K, Mbonde A, et al. Incidence of status migrainosus in Olmsted County, Minnesota, United States: Characterization and predictors of recurrence. Presented at: AHS Annual Scientific Meeting; June 9-11, 2022; Denver, CO.
4. Pradhan A. Harold G. Wolff Award Lecture: Migraine and Peripheral Pain Models Show Differential Alterations in Neuronal Complexity. Presented at: AHS Annual Scientific Meeting; June 9-11, 2022; Denver, CO.